Clinical trials: Lung Cancer Screening Program, open to volunteers
Lung Cancer Screening Program, Artificial Intelligence (AI)
Development of an Artificial Intelligence Model for the Identification and Prevention of Smoking-related Diseases.
The study is an interventional pilot study. The study is designed to be monocentric and it presents additional procedues.
- Trial name
- ARIA (NCT06626178)
- Testing
- Computed tomography (CT) scan low dose, Blood sampling, Tissue sampling (lung)
- Where
- Italy
- Volunteers
- 2,840 people, healthy volunteers welcome
- Sponsor
- Scientific Institute San Raffaele
Lung Cancer, Early Lung Cancer Detection
CHAMP Lung Cancer Screening Program
The U.S. Preventive Services Task Force recommends annual lung cancer screening (LCS) with low-dose CT for adults aged 50-80 with a ≥20 pack-year smoking history who currently smoke or quit within the past 15 years.
- Trial name
- CHAMP (NCT07572773)
- Testing
- DELFI Diagnostics FirstLook Lung Cancer Screening Blood Test, Low-Does CT Scan
- Where
- 3 sites in United States
- Volunteers
- 300 people
- Sponsor
- Jill Kolesar
Lung Cancer
Lung Cancer Screening Program Using Low-dose Tomography and Metabolomic Evaluation in a Public Service.
Observational study that aims to evaluate the implementation of a lung cancer screening program in a smoker population included in a public heath service.
- Trial name
- NCT06376097
- Where
- Brazil
- Volunteers
- 1,000 people
- Sponsor
- AstraZeneca
Heavy Smokers, Lung Cancer Screening
Akershus Cardiac Examination (ACE) 5 Study
Individuals with extensive smoking history have 2- to 3-fold increased risk of dying prematurely compared to age- and gender-matched peers.
- Conditions
- Heavy Smokers, Lung Cancer Screening, Cardiovascular Risk Profile, Cardiovascular Disease Prevention
- Trial name
- ACE5 (NCT07301489)
- Testing
- Lung Cancer Screening Plus Program, Standard of Care
- Where
- Norway
- Volunteers
- 1,000 people
- Sponsor
- University Hospital, Akershus
Lung Cancer Screening Program
Inpatient Capture: A Mixed Methods Study to Develop an Inpatient Lung Cancer Screening Program in a Safety Net Hospital.
Lung cancer continues to be the leading cause of cancer death in the United States. There are several important disparities in lung cancer mortality: racial and ethnic minorities, those with serious mental illness and those with…
- Trial name
- NCT06876831
- Testing
- Shared decision making for LDCT (3 potential outcomes LDCT on discharge, scheduled date of LDCT, or Lung Cancer Screening referral), Inpatient Tobacco Cessation Counseling (Handouts, NYC Quits number, Medication Recommendations to primary team, Smoking cessation referral)
- Where
- United States
- Volunteers
- 150 people, healthy volunteers welcome
- Sponsor
- Physician Affiliate Group of New York
Lung Cancer
Lung Cancer Screening Program in Mexico
This prospective study aims to detect early-stage lung cancer using low-dose computed tomography (LDCT) in Mexicans aged 50 or older who are current or former heavy smokers, non-smokers exposed to significant wood smoke, or…
- Trial name
- DETECTO (NCT06535451)
- Testing
- Screening
- Where
- Mexico
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- Instituto Nacional de Cancerologia de Mexico